481
Views
9
CrossRef citations to date
0
Altmetric
Review

Breast cancer and immunology: biomarker and therapeutic developments

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nehad M Ayoub, Kamal M Al-Shami & Rami J Yaghan. (2019) Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches. Breast Cancer: Targets and Therapy 11, pages 53-69.
Read now
Susanna Gallo, Dario Sangiolo, Fabrizio Carnevale Schianca, Massimo Aglietta & Filippo Montemurro. (2017) Treating breast cancer with cell-based approaches: an overview. Expert Opinion on Biological Therapy 17:10, pages 1255-1264.
Read now

Articles from other publishers (7)

David J Dabbs, Richard S Huang & Jeffrey S Ross. (2022) Novel markers in breast pathology. Histopathology 82:1, pages 119-139.
Crossref
Lydia Xenou & Evangelia A. Papakonstanti. (2020) p110δ PI3K as a therapeutic target of solid tumours. Clinical Science 134:12, pages 1377-1397.
Crossref
Jingping Yuan, Xuehui Shi, Chuang Chen, Huihua He, Lin Liu, Juan Wu & Honglin Yan. (2019) High expression of CD47 in triple negative breast cancer is associated with epithelial‑mesenchymal transition and poor prognosis. Oncology Letters.
Crossref
Xiaoshu Zhu, Eugene J Moylan, Yun Xu, Yufei Yang, Dianna P Porter & Paul Fahey. (2018) Chinese medicine for immunological functions in women with breast cancer or a history of breast cancer. Cochrane Database of Systematic Reviews 2022:4.
Crossref
Ge Ma, Huaxing Huang, Minghui Li, Li Li, Peng Kong, Yichao Zhu, Tiansong Xia & Shui Wang. (2018) Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer. Cancer Biomarkers 22:3, pages 405-415.
Crossref
Cesar August Santa-Maria, Taigo Kato, Jae-Hyun Park, Kazuma Kiyotani, Alfred Rademaker, Ami N. Shah, Leeaht Gross, Luis Z. Blanco, Sarika Jain, Lisa Flaum, Claudia Tellez, Regina Stein, Regina Uthe, William J. Gradishar, Massimo Cristofanilli, Yusuke Nakamura & Francis J. Giles. (2018) A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer. Oncotarget 9:27, pages 18985-18996.
Crossref
Jeffrey S. Ross & Laurie M. Gay. (2017) Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer. Pathology 49:2, pages 120-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.